Cathie Wood’s ARK bolsters Teradyne stock, trims Meta Platforms

Published 22/07/2025, 09:50
Cathie Wood’s ARK bolsters Teradyne stock, trims Meta Platforms

Cathie Wood’s ARK ETFs have once again made significant moves in the stock market on Tuesday, 22 July 2025, with the largest transaction being the purchase of shares in Teradyne Inc (NASDAQ:TER). The investment management firm, known for its focus on disruptive innovation, bought 39,792 shares of Teradyne, a provider of automated test equipment, with the total dollar value of the trade amounting to approximately $3.77 million.

This move comes as part of ARK’s strategy to invest in companies they believe are leading the next wave of technological innovation. Teradyne has been a recurring interest for ARK, as seen in previous trades, including a buy of 4,189 shares on Wednesday, 16 July.

On the selling side, ARK reduced its holdings in Meta Platforms Inc (NASDAQ:META), formerly known as Facebook, by offloading 2,106 shares. The sale is valued at around $1.5 million and continues a trend of ARK divesting from the social media giant, which has been a part of their trading activity in recent days.

In the realm of healthcare, ARK’s ARKG ETF has continued its investment in Caris Life Sciences Inc (CAI), adding 13,036 shares to its portfolio. The transaction is valued at approximately $368,788, mirroring an identical purchase made on Friday, 18 July. Meanwhile, ARK has sold 3,013 shares of Guardant Health Inc (NASDAQ:GH), a precision oncology company, for a total of $137,513.

These trades are part of ARK’s daily adjustments to its ETF portfolios, as the firm seeks to capitalize on market dynamics and align with its long-term investment strategy. Investors and market watchers closely follow ARK’s trades, as Cathie Wood’s investment decisions are often seen as indicators of broader market trends in innovation-focused sectors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.